Suppr超能文献

高敏C反应蛋白和尿酸水平升高可预测二尖瓣反流患者的疾病严重程度。

High levels of high-sensitivity C-reactive protein and uric acid can predict disease severity in patients with mitral regurgitation.

作者信息

Turker Yasin, Ekinozu Ismail, Turker Yasemin, Akkaya Mehmet

机构信息

Department of Cardiology, Duzce University Faculty of Medicine, Duzce, Turkey.

Department of Cardiology, Duzce University Faculty of Medicine, Duzce, Turkey.

出版信息

Rev Port Cardiol. 2014 Nov;33(11):699-706. doi: 10.1016/j.repc.2014.03.014. Epub 2014 Nov 11.

Abstract

INTRODUCTION

Both high-sensitivity CRP (hs-CRP) and uric acid (UA) levels are known to be increased in heart failure patients and are associated with poorer functional capacity and adverse outcome. The role of these markers in patients with mitral regurgitation (MR) is less clear. The aim of this study was to assess the relationship between hs-CRP, UA and organic MR. We also assessed whether hs-CRP and UA levels are correlated with symptoms of MR, severity of MR, LV remodeling and outcome during follow-up.

METHODS

A total of 200 consecutive patients (87 men [43.5%]; mean age 61.6±12.5 years) with moderate or severe isolated and organic MR were included in the study. All the patients were assessed clinically and were managed and treated with standard medical therapy according to evidence-based practice guidelines. Patients were categorized according to New York Heart Association (NYHA) functional class. We assessed and graded the severity of MR using a multiparametric approach. hs-CRP was measured with chemiluminescent immunometric assay using an IMMULITE® 1000 autoanalyzer (Siemens, Germany). Serum UA levels were analyzed using a Cobas® 6000 autoanalyzer (Roche Diagnostics, Mannheim, Germany).

RESULTS

Mean UA levels increased significantly with NYHA class: 4.46±1.58 mg/dl for patients in NYHA class I, 5.91±1.69 mg/dl for class II, 6.31±2.16 mg/dl for class III and 8.86±3.17 mg/dl for class IV (p<0.001). Mean UA levels also increased significantly with increased severity of MR (moderate 5.62±1.9 mg/dl, moderate to severe 5.56±1.2 mg/dl, severe 7.38±3.4 mg/dl, p<0.001). There was a significant correlation between UA level and left ventricular end-diastolic diameter (r=0.40; p<0.001), left ventricular end-systolic diameter (r=0.297; p=0.001) and left ventricular ejection fraction (LVEF) (r=0.195, p=0.036), whereas hs-CRP was not correlated with these parameters. In multivariate Cox proportional hazards analysis LVEF, NYHA class and UA levels were the only independent predictors of death.

CONCLUSION

UA and hs-CRP levels can help identify patients with asymptomatic moderate or severe mitral regurgitation. UA levels may be useful to assess the extent of left ventricular remodeling and in the optimal timing of mitral valve surgery in certain subsets of patients.

摘要

引言

已知高敏C反应蛋白(hs-CRP)和尿酸(UA)水平在心力衰竭患者中会升高,且与较差的功能能力和不良预后相关。这些标志物在二尖瓣反流(MR)患者中的作用尚不清楚。本研究的目的是评估hs-CRP、UA与器质性MR之间的关系。我们还评估了hs-CRP和UA水平是否与MR症状、MR严重程度、左心室重构及随访期间的预后相关。

方法

本研究纳入了200例连续的中度或重度孤立性器质性MR患者(87例男性[43.5%];平均年龄61.6±12.5岁)。所有患者均接受临床评估,并根据循证实践指南接受标准药物治疗和管理。患者根据纽约心脏协会(NYHA)心功能分级进行分类。我们采用多参数方法评估并分级MR的严重程度。hs-CRP采用化学发光免疫分析法,使用IMMULITE® 1000自动分析仪(德国西门子公司)进行检测。血清UA水平使用Cobas® 6000自动分析仪(德国罗氏诊断公司,曼海姆)进行分析。

结果

UA平均水平随NYHA分级显著升高:NYHA I级患者为4.46±1.58mg/dl,II级为5.91±1.69mg/dl,III级为6.31±2.16mg/dl,IV级为8.86±3.17mg/dl(p<0.001)。UA平均水平也随MR严重程度增加而显著升高(中度5.62±1.9mg/dl,中度至重度5.56±1.2mg/dl,重度7.38±3.4mg/dl,p<0.001)。UA水平与左心室舒张末期内径(r=0.40;p<0.001)、左心室收缩末期内径(r=0.297;p=0.001)和左心室射血分数(LVEF)(r=0.195,p=0.036)之间存在显著相关性,而hs-CRP与这些参数无关。在多变量Cox比例风险分析中,LVEF、NYHA分级和UA水平是死亡的唯一独立预测因素。

结论

UA和hs-CRP水平有助于识别无症状性中度或重度二尖瓣反流患者。UA水平可能有助于评估左心室重构程度,并确定某些患者亚组二尖瓣手术的最佳时机。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验